|
1-(5-chlorothiophen-2-yl)-2-{[5-(4-hydroxyphenyl)-1,3,4-oxadiazol-2-yl]sulfanyl}ethanone |
|
Mycobacterium |
ESX-1 (ESAT-6 secretion system-1) |
Preclinical (in vitro) |
Gries R, et al. 2024. Cell Chem Biol |
|
1-(azepan-1-yl)-3-[[5-(3-methylphenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]propan-1-one |
Depiction based on curated SMILES
S
N
O
CH
3
O
N
N
|
Mycobacterium |
ESX-1 (ESAT-6 secretion system-1) |
Preclinical (in vitro) |
Gries R, et al. 2024. Cell Chem Biol |
|
2-(5-Phenyl-[1,3,4]oxadiazol-2-ylsulfanyl)-1-piperidin-1-yl-ethanone |
Depiction based on curated SMILES
O
N
N
S
O
N
|
Mycobacterium |
ESX-1 (ESAT-6 secretion system-1) |
Preclinical (in vitro) |
Gries R, et al. 2024. Cell Chem Biol |
|
Compound 2 (internal name in literature) |
Depiction based on curated SMILES
H
H
3
C
O
NH
H
H
3
C
B
O
H
H
H
H
3
C
O
CH
3
H
3
C
O
H
3
C
H
NH
O
H
CH
3
NH
2
CH
3
HN
H
NH
2
O
N
H
|
Mycobacterium |
ESX-1 (ESAT-6 secretion system-1) |
Preclinical (in vitro) |
Frasinyuk MS, et al. 2014. Bioorg Med Chem Lett |
|
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |